- Ленты заголовков
Headlines
The field is ripe with opportunity — and opportunism. Here’s how to navigate it.
Google is making some changes to how Gemini handles mental health crises. The chatbot now includes a redesigned crisis hotline module with a one-touch interface to connect to real-world help. The company is also changing how Gemini responds to signs that a user may be experiencing a mental health crisis. The redesigned module shows a one-touch interface to text, call or chat with a human crisis agent or visit the 988 website. "Once the interface is activated, the option to reach out for professional help will remain clearly available throughout the remainder of the conversation," the company wrote in a blog post. However, as you can see in the image below, the module includes an option to dismiss it. Not mentioned in Google's announcement is the elephant in the room: a recent lawsuit accusing the chatbot of instructing a man to commit suicide. The family of 36-year-old Jonathan Gavalas, who took his own life last year, sued the company in
AI healthcare diagnostics improve disease detection accuracy and speed, transforming medical care with machine learning and predictive analytics.
Lung cancer remains the leading cause of cancer-related deaths worldwide, accounting for nearly one in five cancer deaths—around 1.8 million lives lost each year. One of the main reasons is late diagnosis: in its early stages, the disease appears as extremely small nodules that are difficult to distinguish from healthy tissue, even for experienced radiologists.
An AI system unearthed a trove of CRISPR-like proteins in minutes instead of weeks or months. The post MIT Mined Bacteria for the Next CRISPR—and Found Hundreds of Potential New Tools appeared first on SingularityHub.
Google wants to help you find mental health support more easily
Modern AI models can create convincing descriptions of images that were never given to them — a phenomenon researchers call a "mirage."
TUESDAY, April 7, 2026 — The number of Americans who want artificial intelligence (AI) involved in their health care is declining, a new survey says.Only 42% are open to AI being used as part of their care, down from 52% in 2024, according to the p...
The Berkeley biotech is backing a Nature-published approach that recreates the embryonic environment where blood stem cells first form, rather than reprogramming aged cells chemically or genetically. Its lead programme targets bone marrow transplant in blood cancers and has received FDA Orphan Drug Designation. HexemBio has publicly launched with a $10.4 million seed round led […] This story continues at The Next Web
Cell and gene therapies are moving towards correcting root causes of diseases. Let's take a look at future cell and gene therapy trends. The post The future of cell & gene therapy: Key trends to watch appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.
Bread and biscuits made from Crispr-edited wheat showed substantially reduced acrylamide levels Scientists have developed gene-edited wheat that can be used to make bread that is less carcinogenic when toasted. Researchers at Rothamsted Research in Harpenden, Hertfordshire, used Crispr genome editing, which allows researchers to selectively edit the DNA of living organisms. This technology was adapted for use in the laboratory from naturally occurring genome editing systems found in bacteria. Continue reading...
Lung cancer remains the leading cause of cancer-related deaths worldwide, accounting for nearly one in five cancer deaths - around 1.8 million lives lost each year.
A high-level government delegation from France, including the head of national investment planning at the ministerial level, visited Lunit to discuss ways to expand medical artificial intelligence across Europe.Lunit said on April 7 that officials from the General Secretariat for Investment (SGPI),
Family physician Eric Boose has been using an artificial intelligence tool to get back to what he calls "old-fashioned medicine" — talking with patients face-to-face, without having to type into a computer at the same time.
Cellular senescence has been increasingly implicated in the development of pulmonary fibrosis, a largely irreversible condition with a poor prognosis under the current standard of care. An early clinical trial of first generation senolytic drugs to clear senescent cells showed promising results, but the condition remains a low priority among companies developing various forms of novel senolytics. Here, researchers discuss one of the primary mechanisms targeted by early senolytics, the BCL-2 protein known to be involved in preventing apoptosis in senescent cells, in the context of pulmonary fibrosis. Idiopathic pulmonary fibrosis (IPF) is a progressive, fatal lung disease that develops in response to chronic epithelial injury. Unlike injury-induced homeostatic lung repair during which fibroblasts undergo apoptosis and clearance, the lungs of IPF patients continue to […]
arXiv:2604.04878v1 Announce Type: new Abstract: This work addresses challenges in evaluating adaptive artificial intelligence (AI) models for medical devices, where iterative updates to both models and evaluation datasets complicate performance assessment. We introduce a novel approach with three complementary measurements: learning (model improvement on current data), potential (dataset-driven performance shifts), and retention (knowledge preservation across modification steps), to disentangle performance changes caused by model adaptations versus dynamic environments. Case studies using simulated population shifts demonstrate the approach's utility: gradual transitions enable stable learning and retention, while rapid shifts reveal trade-offs between plasticity and stability. These measurements provide practical insights for regulatory science, enabling rigorous assessment of the safety and effectiveness of adaptive AI systems over sequential modifications.
arXiv:2604.03774v1 Announce Type: new Abstract: The adoption of vision-language models (VLMs) for wireless network management is accelerating, yet no systematic understanding exists of where these large foundation models outperform lightweight convolutional neural networks (CNNs) for spectrum-related tasks. This paper presents the first diagnostic comparison of VLMs and CNNs for spectrum heatmap understanding in non-terrestrial network and terrestrial network (NTN-TN) cooperative systems. We introduce SpectrumQA, a benchmark comprising 108K visual question-answer pairs across four granularity levels: scene classification (L1), regional reasoning (L2), spatial localization (L3), and semantic reasoning (L4). Our experiments on three NTN-TN scenarios with a frozen Qwen2-VL-7B and a trained ResNet-18 reveal a clear taskdependent complementarity: CNN achieves 72.9% accuracy at severity classification (L1) and 0.552 IoU at spatial localization (L3), while VLM uniquely enables semantic
In a reflection of one increasingly common AI use case, Google today announced a series of Gemini updates to help when users ask about mental health. The company believes that “responsible AI can play a positive role for people’s mental well-being.” more…
Medvi, the AI-powered telehealth company, is fueled by ads from doctors who don't appear to exist Business InsiderHow A.I. Helped One Man (and His Brother) Build a $1.8 Billion Company The New York TimesHow A Telehealth Startup Found Success With Just $20,000 and AI ForbesThe New York Times spotlighted MEDVi. The FDA had already warned the self-proclaimed 'fastest growing company in history.' drugdiscoverytrends.comThe back story behind the first “$1.8 Billion” dollar “AI Company” Marcus on AI | Substack
Medvi, the AI-powered telehealth company, is fueled by ads from doctors who don't appear to exist Business InsiderHow A.I. Helped One Man (and His Brother) Build a $1.8 Billion Company The New York TimesHow A Telehealth Startup Found Success With Just $20,000 and AI ForbesThe New York Times spotlighted MEDVi. The FDA had already warned the self-proclaimed 'fastest growing company in history.' drugdiscoverytrends.comThe back story behind the first “$1.8 Billion” dollar “AI Company” Marcus on AI | Substack
Amid the sweeping integration of artificial intelligence (AI) across various sectors, its encroachment into healthcare has sparked both optimism and caution. A recent comprehensive survey commissioned by The Ohio State University Wexner Medical Center unveils a nuanced portrait of American attitudes toward AI’s role in personal healthcare decisions. The findings reveal a notable decline in […]
Artificial intelligence seems to be everywhere—in our jobs, in our homes and at the doctor's office. While the use of AI grows, a new survey commissioned by The Ohio State University Wexner Medical Center finds fewer Americans are open to AI being used in their health care.
University of Mississippi research offers hope that cancer drug therapies packaged in 3D-printed carriers could deliver medication directly to tumors while reducing many of the side effects that cancer patients endure.
A new study from the University of Minnesota Medical School demonstrated that fecal microbiota transplantation (FMT) can rapidly reverse systemic inflammation and improve survival in patients with fulminant Clostridioides difficile (C. difficile) infection - a life-threatening condition characterized by a sepsis-like state.
University of Mississippi research offers hope that cancer drug therapies packaged in 3D-printed carriers could deliver medication directly to tumors while reducing many of the side effects that cancer patients endure. In a study published in Pharmaceutical Research, the Ole Miss team demonstrated that 3D-printed spanlastics—a tiny carrier filled with cancer-fighting drugs—could be implanted directly at the site of a tumor and kill those cells.
Microplastics were found in each of the human bile samples examined, showing that chronic low-dose exposure can drive mitochondrial dysfunction and senescence in cholangiocytes, with melatonin offering partial protection against this environmentally driven cellular stress. The post Microplastics in Human Bile Drive Mitochondrial Dysfunction and Senescence appeared first on GEN - Genetic Engineering and Biotechnology News.
University of Mississippi Scientists Pioneer 3D-Printed Spanlastics for Targeted Cancer Treatment Recent advancements from the University of Mississippi offer a promising breakthrough in cancer therapy through the development of 3D-printed spanlastic carriers designed to deliver anticancer drugs directly to tumor sites. This cutting-edge approach combines nanotechnology with additive manufacturing, aiming to enhance drug efficacy while […]
In the first of a new series of Keynote Webinars, Professor Rodolphe Barrangou, PhD (North Carolina State; EIC, The CRISPR Journal) offers a front-row perspective of the CRISPR revolution, the seminal advances, clinical highlights, and rising applications. The post CRISPR at 25: The Past, Present, and Future of Genome Editing appeared first on GEN - Genetic Engineering and Biotechnology News.
Cell cultures—single layers of cells grown in a small dish—have enabled researchers to study biological growth, develop or test drugs and even discover what causes some diseases. Cell spheroids, 3D versions of cell cultures built using a process known as cell aggregation, are the next step in advancing this work, capable of more closely modeling real tissue. A new technology, invented by researchers from Penn State and detailed in a paper published in Advanced Science, could breathe fresh air into bottom-up tissue fabrication and potentially large-scale tissue engineering by addressing these issues.
In an era where regenerative medicine and bioelectronics are converging to push the frontiers of healing, a groundbreaking study published in npj Flexible Electronics in 2026 has revealed a transformative approach to nerve repair. The research, led by Wang, E., Huang, J., Shan, Y., and colleagues, introduces bioabsorbable silicon-magnesium (Si-Mg) galvanic cells integrated within flexible […]
Lung transplantation remains a vital intervention for patients with end-stage pulmonary diseases, offering renewed hope and extending survival. Despite advances in surgical techniques and immunosuppressive regimens, post-transplant complications continue to pose significant challenges. Among these, acute kidney injury (AKI) emerges as a particularly frequent and consequential complication, often precipitating a cascade of adverse outcomes. Critically, […]
In a groundbreaking advancement poised to reshape the trajectory of immunology and regenerative medicine, researchers at the Mayo Clinic have unveiled a novel quantitative method designed to predict which proteins possess the highest potential to elicit immune responses. This innovative approach, detailed in a recent publication in the journal Biomaterials, affronts the previously held notion […]
Edward J. Holland, MD, cofounded the Holland Foundation for Sight Restoration because he knew he had a good idea, but that idea just was not catching on.Holland pioneered the Cincinnati Protocol of ocular surface stem cell transplantation by borrowing from renal transplant specialists and using preoperative testing of donors and recipients and full dosing of long-term systemic immunosuppression to prevent rejection. With this approach of managing ocular surface stem cells, he was able to significantly improve the outcomes of these procedures, which had been abandoned by most corneal surgeons
Mayo Clinic researchers have developed a new method to identify which proteins are most likely to trigger an immune response—a discovery that could help improve transplant care, regenerative medicine and other areas where the immune system plays a critical role. The results, published in Biomaterials, challenge a common assumption in the field that all proteins are equally likely to provoke immune reactions.
A New Milestone in Cardiovascular Research Do you know? The death caused by Cardiovascular diseases ranks one amongst the mortality rate by any disease. Though we have evolved in the health sciences and technology, it remains a matter of concern. To find a solution, Chinese researchers have taken a significant step forward in cardiovascular research. […] The post World-First Gene-Edited Pigs Could Revolutionize Cardiovascular Research appeared first on BioTecNika.
Longevity Isn’t Equal: Why Life-Extending Treatments May Be a “Biological Lottery” SciTechDaily
Longevity Isn’t Equal: Why Life-Extending Treatments May Be a “Biological Lottery” SciTechDaily
Out-of-sequence kidney transplants, including unilateral allocations, increased substantially between 2020 and 2024, according to study data published in JAMA Network Open.Out-of-sequence kidney transplant allocations are used by organ procurement organizations to transplant a kidney outside of the standardized wait-list sequence, according to Miko E. Yu, MA, of the Columbia University Renal Epidemiology Group, and colleagues. By examining unilateral allocations, in which one kidney is donated in sequence and the other donated out of sequence from the same donor, the researchers could assess
In allogeneic haematopoietic cell transplant recipients, ciprofloxacin prophylaxis may reduce bloodstream infections but is tied to higher rates of antimicrobial resistance and antibiotic use.
Kakao Healthcare has signed a memorandum of understanding with Sanofi-Aventis Korea to jointly conduct real-world evidence research and develop artificial intelligence (AI) solutions using medical data, the digital health care company said Monday. The memorandum was signed Friday during the Korea-France Economic Future Dialogue, held alongside French President Emmanuel Macron’s visit to Korea, which marked the 140th anniversary of diplomatic ties between the two countries. The companies said they will jointly conduct real-world evidence (RWE) studies using health care data, while developing and advancing AI models through federated learning. Kakao Healthcare said it will provide platforms and technologies capable of supporting research based on real clinical data, while Sanofi will contribute its expertise in AI, digital health care and medical science. The companies said they will explore applications including early disease detection and personalized patient care, focusing on
Clinicians can reasonably include Mediterranean-style eating in respiratory prevention counseling — alongside smoking cessation, exercise, weight control, and exposure reduction.
arXiv:2604.03203v1 Announce Type: new Abstract: Three-dimensional medical image data and computer-aided decision making, particularly using deep learning, are becoming increasingly important in the medical field. To aid in these developments we introduce PR3DICTR: Platform for Research in 3D Image Classification and sTandardised tRaining. Built using community-standard distributions (PyTorch and MONAI), PR3DICTR provides an open-access, flexible and convenient framework for prediction model development, with an explicit focus on classification using three-dimensional medical image data. By combining modular design principles and standardization, it aims to alleviate developmental burden whilst retaining adjustability. It provides users with a wealth of pre-established functionality, for instance in model architecture design options, hyper-parameter solutions and training methodologies, but still gives users the opportunity and freedom to ``plug in'' their own solutions or modules.
arXiv:2604.02707v1 Announce Type: new Abstract: Humanoid robot technologies have demonstrated immense potential for minimally invasive surgery (MIS). Unlike dedicated multi-arm surgical platforms, the inherent dual-arm configuration of humanoid robots necessitates an efficient instrument exchange capability to perform complex procedures, mimicking the natural workflow where surgeons manually switch instruments. To address this, this paper proposes an immersive teleoperated rapid instrument exchange system. The system utilizes a low-latency mechanism based on single-axis compliant docking and environmental constraint release. Integrated with real-time first-person view (FPV) perception via a head-mounted display (HMD), this framework significantly reduces operational complexity and cognitive load during the docking process. Comparative evaluations between experts and novices demonstrate high operational robustness and a rapidly converging learning curve; novice performance in
arXiv:2604.02552v1 Announce Type: new Abstract: We introduce chaos-controlled Reservoir Computing (cc-RC) for living neural cultures: dynamically rich substrates of unique potential for adaptive computation. To account for intrinsic biological variability, cc-RC combines: (i) pre-training identification of each culture's dynamical signature and phase-portrait attractor; (ii) low-power optical chaos control to stabilize spontaneous and stimulus-evoked activity; (iii) readout training within this controlled regime. Across hundreds of neural samples, cc-RC enables robust learning and pattern classification, improving both accuracy and model longevity by approximately 300% over standard RC. We further propose Knowledge Transplant (KT), for which the reservoir map learned by an expert culture is transplanted to an attractor-equivalent student culture, reducing training time to minutes while improving performance. By enabling cross-substrate, reusable learned models, KT paves the way for
Running a capable large language model usually means relying proprietary cloud services or investing in multiple high-end graphics cards.
Efforts to extend life may be succeeding, but not equally. Extending life is only part of the goal in aging research. Scientists also want more people to reach old age in good health, with fewer differences in when individuals die. This ideal outcome is often described as “squaring the survival curve,” where most deaths are [...]
One way to live longer: Win the genetic lottery The Washington PostSleep duration and genetics interact to affect functional health News-MedicalThe correlation between longevity & genetics WFLAGenes found to outweigh lifestyle in lifespan MSN
One way to live longer: Win the genetic lottery The Washington PostSleep duration and genetics interact to affect functional health News-MedicalThe correlation between longevity & genetics WFLAGenes found to outweigh lifestyle in lifespan MSN
In an era marked by rapid advancements in targeted therapies for hematologic malignancies, the management of relapsed or refractory mantle cell lymphoma (MCL) remains a formidable challenge for clinicians. Mantle cell lymphoma, a rare and aggressive subtype of non-Hodgkin lymphoma, frequently exhibits resistance to initial treatment modalities, necessitating innovative therapeutic approaches to improve survival outcomes. […]
Millions of people are turning to artificial intelligence (AI) chatbots for advice on everything from cooking to tax returns. Increasingly, they are also asking chatbots about their health.
A transplant drug that has been used for decades can preserve the function of insulin-producing cells in young children who are newly diagnosed with type 1 diabetes.
The funds that the Sicilian Region has allocated to the cities of Palermo, Messina and Catania for the construction of strategic works for mobility, infrastructure ... Read more L’article Messina: 16.6 million from the Region for urban regeneration and mobility est apparu en premier sur Odnako.
It is safe for patients to receive a donor liver that has been intentionally preserved overnight using machine perfusion to enable a daytime transplant.
A groundbreaking new study, published in the journal Biochar, sheds fresh light on the intricate effects of biochar on soil emissions of nitrous oxide (N₂O), a highly potent greenhouse gas. Researchers have long touted biochar, a carbon-enriched material derived from biomass, as a promising solution to climate change due to its potential for enhancing soil […]
Robert Hart / The Verge: Utah launches a one-year pilot program allowing Legion Health's AI chatbot to renew prescriptions for 15 low-risk psychiatric maintenance medications — Some psychiatrists are asking what problem, exactly, this is solving. … Utah is allowing an AI system to prescribe psychiatric drugs without a doctor.
It is safe for patients to receive a donor liver that has been intentionally preserved overnight using machine perfusion to enable a daytime transplant. This is shown by a study performed at the University Medical Center Groningen (UMCG) in the Netherlands, including transplants using all types of donor organs. The post-transplant outcomes are at least as good as those for livers that were not treated with machine perfusion, or were treated for only a short time, prior to transplantation.
In a preclinical animal study, implantation of lab-grown esophageal grafts restored swallowing, offering hope for infants with long-gap esophageal atresia.
arXiv:2604.02227v1 Announce Type: cross Abstract: We consider a stopping problem and its application to the decision-making process regarding the optimal timing of organ transplantation for individual patients. At each decision period, the patient state is inspected and a decision is made whether to transplant. If the organ is transplanted, the process terminates; otherwise, the process continues until a transplant happens or the patient dies. Under suitable conditions, we show that there exists a control limit optimal policy. We propose a smoothed perturbation analysis (SPA) estimator for the gradient of the total expected discounted reward with respect to the control limit. Moreover, we show that the SPA estimator is asymptotically unbiased.
arXiv:2604.02227v1 Announce Type: cross Abstract: We consider a stopping problem and its application to the decision-making process regarding the optimal timing of organ transplantation for individual patients. At each decision period, the patient state is inspected and a decision is made whether to transplant. If the organ is transplanted, the process terminates; otherwise, the process continues until a transplant happens or the patient dies. Under suitable conditions, we show that there exists a control limit optimal policy. We propose a smoothed perturbation analysis (SPA) estimator for the gradient of the total expected discounted reward with respect to the control limit. Moreover, we show that the SPA estimator is asymptotically unbiased.
arXiv:2604.02218v1 Announce Type: cross Abstract: Ultra-narrow-linewidth lasers with suppressed high-frequency phase noise are critical for quantum control and precision metrology. While optical phase locking (OPL) is the standard technique for cloning the coherence of such sources, its effectiveness is often limited at high frequencies by feedback latency. We present a robust feedforward architecture that overcomes this limitation by recycling and demodulating the existing master-slave beat signal to drive a single electro-optic modulator for near-instantaneous noise cancellation. This approach eliminates the extraneous sidebands and transmission losses typical of more complex modulators. Through active stabilization of the beat amplitude and demodulation phase, we demonstrate robust suppression exceeding 30 dB from 10 kHz to 10 MHz. This hardware-efficient framework is readily compatible with standard OPL setups, offering a scalable solution for high-fidelity coherent control.
arXiv:2604.02227v1 Announce Type: new Abstract: We consider a stopping problem and its application to the decision-making process regarding the optimal timing of organ transplantation for individual patients. At each decision period, the patient state is inspected and a decision is made whether to transplant. If the organ is transplanted, the process terminates; otherwise, the process continues until a transplant happens or the patient dies. Under suitable conditions, we show that there exists a control limit optimal policy. We propose a smoothed perturbation analysis (SPA) estimator for the gradient of the total expected discounted reward with respect to the control limit. Moreover, we show that the SPA estimator is asymptotically unbiased.
arXiv:2604.01898v1 Announce Type: new Abstract: Artificial intelligence (AI) systems accelerate medical workflows and improve diagnostic accuracy in healthcare, serving as second-opinion systems. However, the unpredictability of AI errors poses a significant challenge, particularly in healthcare contexts, where mistakes can have severe consequences. A widely adopted safeguard is to pair predictions with uncertainty estimation, enabling human experts to focus on high-risk cases while streamlining routine verification. Current uncertainty estimation methods, however, remain limited, particularly in quantifying aleatoric uncertainty, which arises from data ambiguity and noise. To address this, we propose a novel approach that leverages disagreement in expert responses to generate targets for training machine learning models. These targets are used in conjunction with standard data labels to estimate two components of uncertainty separately, as given by the law of total variance, via a
arXiv:2604.01449v1 Announce Type: new Abstract: Artificial intelligence (AI) systems are increasingly integrated into healthcare and pharmacy workflows, supporting tasks such as medication recommendations, dosage determination, and drug interaction detection. While these systems often demonstrate strong performance under standard evaluation metrics, their reliability in real-world decision-making remains insufficiently understood. In high-risk domains such as medication management, even a single incorrect recommendation can result in severe patient harm. This paper examines the reliability of AI-assisted medication systems by focusing on system failures and their potential clinical consequences. Rather than evaluating performance solely through aggregate metrics, this work shifts attention towards how errors occur and what happens when AI systems produce incorrect outputs. Through a series of controlled, simulated scenarios involving drug interactions and dosage decisions, we analyse
Tissue repair is not a single event. It is a coordinated response involving inflammation, cellular signaling, and gradual rebuilding. Understanding how this process unfolds provides valuable insight into why recovery takes time, and why it does not always follow a predictable path.
The Information: Source: Anthropic has acquired Coefficient Bio, which was developing a platform that enables AI to run biotech tasks such as planning drug research, for ~$400M — Anthropic has acquired AI biotech startup Coefficient Bio for roughly $400 million, according to a person with knowledge of the deal.
Scientists at Rothamsted Research have successfully developed wheat with dramatically reduced levels of asparagine, without affecting yield, using gene editing techniques, offering a promising route to safer food production and improved regulatory compliance. Results from two years of field trials demonstrate that wheat produced using CRISPR genome editing can significantly lower concentrations of free asparagine—an amino acid that converts into acrylamide, a toxic and probably carcinogenic compound formed during everyday baking, frying, and toasting.
In a groundbreaking advancement at the intersection of cytoskeletal biology and regenerative medicine, researchers have unveiled a novel mechanism that significantly accelerates the differentiation of pluripotent stem cells into pancreatic islet cells by targeting the dynamics of the actin cytoskeleton. The study, conducted by Hogrebe, Schmidt, Augsornworawat, and colleagues and recently published in Nature Communications, […]
Artificial intelligence has already proven it can perform specific medical tasks, such as interpreting X-rays or flagging risks in patient data. But caring for patients is a dynamic process that unfolds over time, requiring clinicians to interpret signals from multiple sources and intervene as a patient's condition changes. Stabilizing a patient may require a physician to synthesize lab values and medical images, listen to lung or heart sounds, observe physical responses, and decide when to escalate care—often under severe time pressure.
Robert Hart / The Verge: Mental health startup Kintsugi is shutting down and open-sourcing its AI tech to detect depression and anxiety, after failing to secure FDA clearance — Instead, a mental health startup shut down and open-sourced its tech. … For the past seven years, the California-based startup Kintsugi …
Inhibiting AhR, a xenobiotic sensor protein, lifts a molecular brake on axon regeneration and pushes injured neurons from stress management towards growth in nerve and spinal cord injury models, scientists say. The post Blocking AhR Sensor Activates Regenerative Program in Injured Neurons appeared first on GEN - Genetic Engineering and Biotechnology News.
Some women with complex chronic illnesses are using chatbots to search for diagnoses or relief from their symptoms.
For the past seven years, the California-based startup Kintsugi has been developing AI designed to detect signs of depression and anxiety from a person's speech. But after failing to secure FDA clearance in time, the company is shutting down and releasing most of its technology as open-source. Some elements may even find a second life beyond healthcare, like detecting deepfake audio. Mental health assessments still largely rely on patient questionnaires and clinical interviews, rather than the lab tests or scans common in physical medicine. Instead of focusing on what someone is saying, Kintsugi's software analyzes how it is being said. Th … Read the full story at The Verge.
Hara hachi bu, a traditional Japanese practice of eating until you’re about 80% full, is gaining attention as a simple yet powerful way to improve health and reshape our relationship with food. Rather than promoting strict dieting, it encourages slowing down, tuning into hunger cues, and eating with awareness and gratitude. Research suggests it may help reduce calorie intake, support healthier food choices, and prevent long-term weight gain.
Graz University of Technology, the University of Graz and the Medical University of Graz have jointly developed an interactive system that automatically adapts evidence-based medical information to patients' prior knowledge and needs.
Erin Griffith / New York Times: How AI helped Medvi, a telehealth provider of GLP-1 weight-loss drugs with just two full-time employees, hit $401M in 2025 sales, as it tracks for $1.8B in 2026 — Matthew Gallagher took just two months, $20,000 and more than a dozen artificial intelligence tools to get his start-up off the ground.
This week we welcome Magdalena Tyrpien, CEO of Nionyx Bio, just days after the company took first place in the BIO-Europe Spring Startup Spotlight competition in Lisbon. The post Nionyx Bio’s kidney gene therapy wins the 2026 BIO-Europe Spring Startup Spotlight appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.
Jenny McCarthy dismisses Jim Carrey clone rumours, saying fans missed the real change: his happiness at the César Awards.
New results from a clinical trial show promising outcomes for a gene-edited treatment for severe sickle cell disease, a genetic blood disorder with few curative options.
In a groundbreaking advancement poised to redefine cardiovascular health diagnostics, researchers Hasan and Dhrubo have unveiled an innovative artificial intelligence (AI) framework that not only improves the accuracy of cardiovascular disease (CVD) diagnosis but also ensures the interpretability and ethical responsibility of AI applications in healthcare. Published in Scientific Reports in 2026, their work addresses […]
In a groundbreaking study set to reshape our understanding of neuronal repair, researchers have unveiled a novel mechanism by which the aryl hydrocarbon receptor (AhR) modulates axon regeneration through an intricate stress–growth switch. This work, spearheaded by Halawani and colleagues, dives deep into the cellular and molecular dynamics governing nerve injury recovery, revealing insight critical […]
If you own a Fitbit, keep an eye out for these upgrades.
In recent years, lung cancer screening programs across the United States have brought to light approximately 1.6 million suspicious lung nodules annually. This surge in detection presents a formidable challenge to pulmonologists and oncologists alike. While the overwhelming majority of peripheral pulmonary lesions identified through screening are benign, it is their malignant counterparts that remain […]
A revolutionary breakthrough in the treatment of severe sickle cell disease (SCD) has been reported from the latest data emerging from the multicenter RUBY Trial, producing highly promising outcomes that could redefine therapeutic strategies for this challenging genetic blood disorder. The findings, published in the prestigious New England Journal of Medicine, demonstrate unprecedented clinical success […]
The one-of-a-kind model gathers trial ownership, mission-driven investors, public funding, and community dollars into a single capital stack. The post Inside Cairnspring Mill’s bold new model for financing regenerative food systems appeared first on AgFunderNews.
PRISM ALS aims to develop, evaluate, and make available a diverse panel of well-characterized, patient-derived induced pluripotent stem cell (iPSC) models that capture both genetic and sporadic forms of ALS. The post Biological Complexity of ALS to Be Addressed by the Development of New Stem Cell Models appeared first on GEN - Genetic Engineering and Biotechnology News.
New results from a clinical trial show promising outcomes for a gene-edited treatment for severe sickle cell disease, a genetic blood disorder with few curative options. After research conducted as part of the multicenter RUBY Trial, researchers have published their latest findings in the New England Journal of Medicine. Remarkably, 27 out of 28 patients did not have any painful sickle cell crises after treatment, achieving what physicians call a "functional cure."
Last year's successful treatment of an infant known as Baby KJ encouraged scientists to try again. But now, five weeks after the FDA outlined its plans to make such individualized genetic medicines more accessible, researchers ...
As lung cancer screening identifies an estimated 1.6 million suspicious lung nodules each year in the U.S. alone, physicians face a challenge. Most peripheral pulmonary lesions are benign, yet the malignant minority represent the leading cause of cancer death for both men and women. Robotic bronchoscopy may provide a less invasive and more precise approach to diagnosing lung cancer, suggests a five-year, multisite Mayo Clinic study published in Mayo Clinic Proceedings.
In collaboration with researchers in South Korea, a team from The Hospital for Sick Children (SickKids) has discovered a promising therapeutic target in fat tissue that improves cellular function, reduces inflammation, and may protect against obesity-related diseases. The study was published in Nature Communications.
Experiments conducted in Brazil using laboratory rats have shown that graphene-based structures can act as a powerful ally in bone regeneration. These structures are made of sheets of the chemical element carbon that are just one atom thick. They can help heal fractures or bone loss. In the tests, the biocompatible matrix containing graphene facilitated nearly 90% repair of the damage sustained by the test subjects one month after the fracture was induced in the laboratory—a superior performance to that of other materials used in the research.
Researchers at Baylor College of Medicine and collaborating institutions took a closer look at how the gastrointestinal tissue repairs itself. They reveal in the Proceedings of the National Academy of Sciences key players and their connections in the repair process and suggest the possibility that they also may contribute to the repair of other types of tissues.
A research team from the Department of Orthopedics and Traumatology, School of Clinical Medicine, LKS Faculty of Medicine at the University of Hong Kong (HKUMed), has developed a titanium implant surface that can be activated by near-infrared (NIR). With just 15 minutes of NIR irradiation, this surface can eliminate 99.94% of Staphylococcus aureus (S. aureus) biofilms without the use of antibiotics, while simultaneously promoting bone-implant fusion.
In the rapidly evolving landscape of healthcare technology, the integration of artificial intelligence (AI) into clinical workflows offers promising avenues to address persistent challenges, notably clinician burnout. A groundbreaking large-scale observational study recently published in JAMA explores the real-world impact of AI-enabled ambient documentation systems, commonly known as “AI scribes,” on clinician time management and […]